Publications by authors named "John McCarty"

Claim this Profile
C
CHARM is Prognostic of Geriatric Morbidity and Toxicity after Allogeneic Transplant for Older Adults: BMT CTN 1704 Study.
Andrew S Artz, Brent R Logan, Wael Saber, Nancy Geller, Anna Bellach, John McCarty

Blood Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel composite health assessment risk model for older allogeneic transplant recipients: BMT-CTN 1704.
Mohamed L Sorror, Wael Saber, Brent Logan, Nancy Geller, Anna Bellach, John M McCarty

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous Transplant or CAR-T as Consolidation Options in MYC Rearranged Large B-Cell Lymphoma Patients in Remission After Salvage Treatments.
Fateeha Furqan, Kwang W Ahn, Manmeet Kaur, Jinalben Patel, Stephen Ansell, John McCarty

Am J Hematol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postural Orthostatic Tachycardia Syndrome and Orthostatic Hypotension Following Hematopoietic Stem Cell Transplantation.
Georgia K Thomas, Josh West, Michele Golino, Emily Kontos, Emily Federmann, John McCarty

JACC CardioOncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study.
Mary Eapen, Joseph H Antin, Jakub Tolar, Sally Arai, Mitchell E Horwitz, John M McCarty

EClinicalMedicine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study.
Joshua A Hill, Michael J Martens, Jo-Anne H Young, Kavita Bhavsar, Jianqun Kou, John McCarty

Clin Infect Dis· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101).
Joshua A Hill, Michael J Martens, Jo-Anne H Young, Kavita Bhavsar, Jianqun Kou, John McCarty

medRxiv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous exercise stress cardiac magnetic resonance and cardiopulmonary exercise testing to elucidate the Fick components of aerobic exercise capacity: a feasibility and reproducibility study and pilot study in hematologic cancer survivors.
Justin M Canada, John McCarty, Jennifer H Jordan, Cory R Trankle, Kevin DeCamp

Cardiooncology· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study.
Joshua A Hill, Michael J Martens, Jo-Anne H Young, Kavita Bhavsar, Jianqun Kou, John McCarty

EClinicalMedicine· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow Donor Program-Sponsored Prospective Clinical Trial.
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, Brent R Logan, Farhad Khimani, John M McCarty

Transplant Cell Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel rapid-acting sublingual nicotine tablet as a cigarette substitution strategy.
Jed E Rose, Frederique M Behm, Tanaia L Botts, David R Botts, Perry N Willette, John McCarty

Psychopharmacology (Berl)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101Open for Accrual June 2012Open for Accrual June 2012.
Claudio G Brunstein, Paul V O'Donnell, Brent Logan, Peter Dawson, Luciano Costa, John McCarty

Transplant Cell Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of time to relapse on overall survival in patients with mantle cell lymphoma following autologous haematopoietic cell transplantation.
Peter A Riedell, Mehdi Hamadani, Kwang W Ahn, Carlos Litovich, Claudio G Brunstein, John M McCarty

Br J Haematol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
National Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant Cyclophosphamide.
Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, Brent R Logan, Farhad Khimani, John M McCarty

J Clin Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Killer Immunoglobulin-Like Receptor-Ligand Interactions Predict Clinical Outcomes following Unrelated Donor Transplantations.
Elizabeth Krieger, Roy Sabo, Sanauz Moezzi, Caitlin Cain, Catherine Roberts, John McCarty

Biol Blood Marrow Transplant· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing post allograft relapse of myeloid neoplasms: azacitidine and donor lymphocyte infusions as salvage therapy.
John Claiborne, Dipankar Bandyopathyay, Catherine Roberts, Kelly Hawks, May Aziz, John McCarty

Leuk Lymphoma· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Related peripheral blood stem cell donors experience more severe symptoms and less complete recovery at one year compared to unrelated donors.
Michael A Pulsipher, Brent R Logan, Deidre M Kiefer, Pintip Chitphakdithai, Marcie L Riches, John M McCarty

Haematologica· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study.
Michael A Pulsipher, Brent R Logan, Pintip Chitphakdithai, Deidre M Kiefer, Marcie L Riches, John M McCarty

Biol Blood Marrow Transplant· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance azacitidine after myeloablative allogeneic hematopoietic cell transplantation for myeloid malignancies.
Kathryn T Maples, Roy T Sabo, John M McCarty, Amir A Toor, Kelly G Hawks

Leuk Lymphoma· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The influence of lymphoid reconstitution kinetics on clinical outcomes in allogeneic stem cell transplantation.
David J Kobulnicky, Roy T Sabo, Shashank Sharma, Ali S Shubar Ali, Kristen M Kobulnicky, John M McCarty

Leuk Lymphoma· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autologous stem-cell transplant for metastatic renal medullary carcinoma.
Marcus A Carden, Eva Perdahl-Wallace, Jay Greenberg, John M McCarty

Pediatr Blood Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.
Tessa M Andermann, Jonathan U Peled, Christine Ho, Pavan Reddy, Marcie Riches, John M McCarty

Biol Blood Marrow Transplant· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report.
Ivana N Micallef, Patrick J Stiff, Auayporn P Nademanee, Richard T Maziarz, Mitchell E Horwitz, John M McCarty

Biol Blood Marrow Transplant· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low-dose splenic irradiation prior to hematopoietic cell transplantation in hypersplenic patients with myelofibrosis.
Noah S Kalman, Nitai D Mukhopadhyay, Catherine H Roberts, Harold M Chung, William B Clark, John M McCarty

Leuk Lymphoma· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study.
Paolo Anderlini, Juan Wu, Iris Gersten, Marian Ewell, Jakob Tolar, John McCarty

Lancet Haematol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis